GE Healthcare Technologies Inc (GEHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,312,000 | 823,000 | 388,000 | 1,614,000 | 1,198,000 |
| Depreciation Amortization | 440,000 | 297,000 | 148,000 | 610,000 | 466,000 |
| Accounts receivable | 101,000 | 126,000 | 165,000 | -173,000 | -73,000 |
| Accounts payable and accrued liabilities | -67,000 | -97,000 | 31,000 | -100,000 | -180,000 |
| Other Working Capital | -335,000 | -522,000 | -12,000 | 178,000 | -306,000 |
| Other Operating Activity | -409,000 | -327,000 | -301,000 | -28,000 | -54,000 |
| Operating Cash Flow | $1,042,000 | $300,000 | $419,000 | $2,101,000 | $1,051,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -299,000 | -209,000 | -145,000 | -386,000 | -292,000 |
| Net Acquisitions | -259,000 | -259,000 | N/A | -147,000 | -147,000 |
| Purchase Of Investment | -33,000 | -30,000 | -19,000 | -48,000 | -21,000 |
| Other Investing Activity | -83,000 | -39,000 | -24,000 | 23,000 | -10,000 |
| Investing Cash Flow | $-674,000 | $-537,000 | $-188,000 | $-558,000 | $-470,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,000 | -12,000 | -9,000 |
| Debt Issued | 994,000 | 1,000 | 1,000 | 2,006,000 | 2,020,000 |
| Debt Repayment | -162,000 | -156,000 | -153,000 | -855,000 | -9,000 |
| Common Stock Issued | 31,000 | 24,000 | 16,000 | 34,000 | 31,000 |
| Dividend Paid | -41,000 | -28,000 | -14,000 | -41,000 | -28,000 |
| Other Financing Activity | -118,000 | -51,000 | -4,000 | -1,610,000 | -1,583,000 |
| Financing Cash Flow | $704,000 | $-210,000 | $-153,000 | $-478,000 | $422,000 |
| Exchange Rate Effect | -2,000 | -41,000 | -19,000 | -10,000 | -34,000 |
| Beginning Cash Position | 2,506,000 | 2,506,000 | 2,506,000 | 1,451,000 | 1,451,000 |
| End Cash Position | 3,572,000 | 2,018,000 | 2,565,000 | 2,506,000 | 2,420,000 |
| Net Cash Flow | $1,066,000 | $-488,000 | $59,000 | $1,055,000 | $969,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,042,000 | 300,000 | 419,000 | 2,101,000 | 1,051,000 |
| Capital Expenditure | -299,000 | -209,000 | -145,000 | -387,000 | -293,000 |
| Free Cash Flow | 743,000 | 91,000 | 274,000 | 1,714,000 | 758,000 |